Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H2, 2017

Price :
Published : Jul-2017
No. of Pages : 849

Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H2, 2017


GlobalData’s clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H2, 2017” provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Diffuse Large B-Cell Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Roche Diagnostics International Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory information, workflow and data management software; and instruments and reagents for life science research. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. It has operations in the Americas, Asia Pacific, Africa, the Middle East and Europe. Roche Diagnostics manages all the central functions of the Diagnostics business of F. Hoffmann-La Roche Ltd and is headquartered in Rotkreuz, Switzerland. Roc......

AMAG Pharmaceuticals Inc (AMAG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) to reduce the risk of preterm birth in women, Feraheme (ferumoxytol) for iron deficiency anemia in adult patients with chronic kidney disease and MuGard Oral Mucoadhesive for the management of oral mucositis and all types of oral wounds including aphthous ulcers/canker sores and traumatic ulcers. AMAG also provides services related to the collection, processing and storage of umbilical cord blood stem cell and cord tissue units. The company offers these products through direct sales and a netwo......

Veloxis Pharmaceuticals AS (VELO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Veloxis Pharmaceuticals A/S (Veloxis) is a specialty pharmaceutical company, which develops therapies for kidney transplantation based on its proprietary MeltDose platform. MeltDose is a drug delivery technology, used to enhance oral bioavailability and control release of a drug. The company's product portfolio consists of Envarsus XR, anti-rejection drug for patients who had kidney transplantation; and Fenoglide for the treatment of dyslipidemia. The company out licensed the commercial rights of Fenoglide for the US, Canada and Mexico; and Envarsus to Chiesi in Europe, Turkey and CIS countries. It has a wholly owned subsidiary, Veloxis Pharmaceuticals Inc., in New Jersey, the US. Veloxis is headquartered in Copenhagen, Denmark. Veloxis Pharmaceuticals AS (VELO) - Pharmaceuticals......

Brookdale Senior Living Inc (BKD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Brookdale Senior Living Inc (Brookdale) operates senior living communities which provide properties with high quality service, care and living accommodations for residents. The company focuses on providing an independent living, assisted living, dementia care, skilled nursing, continuing care, retirement communities (CCRC) and living accommodations for residents. It also provides housing, hospitality services, ancillary services and health care services. The ancillary services programs, provides outpatient therapy, home health, personalized living and hospice services to residents and to seniors living outside communities. The company also offers management services to third parties. Brookdale is headquartered in Tennessee, the US. Brookdale Senior Living Inc (BKD) - Pharmaceutic......

Aviragen Therapeutics Inc (AVIR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, oral broad spectrum capsid inhibitor of enteroviruses, including human rhinovirus; BTA074, a Phase 2 topical antiviral treatment for genital warts; BTA585, an oral fusion protein inhibitor that Aviragen is developing for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a long-acting neuraminidase inhibitor for influenza A and B infections. The Company also has a preclinical RSV non-fusion inhibitor program for its F-protein inhibitor BTA585. Aviragen is headquartered in Alph......

BioCryst Pharmaceuticals Inc (BCRX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary BioCryst Pharmaceuticals Inc (BioCryst) designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. Biocryst integrates disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. The company's products include peramivir injections Rapivab, Alpivab, Rapiacta and Peramiflu for the treatment of Influenza. The company has strategic partnerships with corporate and academic institutes. It has two wholly owned subsidiaries JPR Royalty Sub LLC and MDCP LLC. BioCryst has research op......

OraSure Technologies Inc (OSUR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to various hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company s......

Rite Aid Corp (RAD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Rite Aid Corp (Rite Aid) is retail drugstore chain. The company sells prescription drugs and a wide range of other merchandise such as, over-the-counter (OTC) medications, personal care items, health and beauty aids, cosmetics, household items, beverages, convenience foods, greeting cards, seasonal merchanise, photo processing and others. Rite Aid services portfolio include pharmacy-related solutions including fully integrated mail, specialty and compounding pharmacy services. The company also has a technology which helps its customer to fill or refill their prescription through internet under website www.riteaid.com. It operates through subsidiaries and retail drugstores in the US. Rite Aid is headquartered in Camp Hill, Pennsylvania, the US. Rite Aid Corp (RAD) - Pharmaceutical......

Biotest AG (BIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Biotest AG (Biotest) is a provider of pharmaceutical and biotherapeutic drugs which develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin and monoclonal antibodies in clinical development. The company specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest distributes its products through local marketing partners and distributors in Europe, North America, South America, Asia, the Middle East and Africa. It has subsidiaries and sales companies in Austria, Switzerland, France, Great Britain, Italy, Hungary, Spain and in Brazil. Biotest is headquartered in Dreieich, Hessen, Germany. Biotest AG......

Emisphere Technologies Inc (EMIS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Emisphere Technologies Inc (Emisphere) is a specialty pharmaceutical and drug delivery company. The company in partnership with global pharmaceutical companies develops novel oral formulations of existing injectable bio-pharmaceutical products, besides new chemical entities, using its Eligen technology. Its lead product Eligen B12, is the first and only once-daily oral prescription medical food approved in the US for treatment of vitamin b12 deficiency. The product is sold through a range of distributors, sellers, and other sources. Emisphere also uses its proprietary Eligen technology to produce novel oral formulations of therapeutic agents. The company's product pipeline includes prescription drugs and medical food products that are being developed in partnership or internally. ......